Immix Biopharma | Investor Presentation Deck

Slide schematic 5/5

diagram 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1

Components 5

process bullet paragraph source-note headline

Tools 1

list/bullet: Purpose-Built Cell Therapy Evidence Capture Engine + Relational Database; Proprietary EXPAND technology; Atomized, Novel Binding Scaffold Generation Engine

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

comparison-frame 90%

Side-by-side structural comparison of Abecma and NXC-201

Find anything

The slide uses a structural diagram to highlight the substitution of the 'Tumor Binding Domain' with the 'COBRA Binder' in the NXC-201 molecule.